Prior to Trump’s pharma tariff and H-1B visa fee shocks, the MSCI India gauge had risen for three straight weeks, adding more than 4% in what was its longest run since May
Source: Bloomberg
Saturday, 04. October 2025
Share:
27. September 2025 06:45
Trump’s dual shocks thwart bets on Indian stock market rebound
